what is a glp-1 drug New Guidelines for Type 2 Diabetes in 2025 GLP-1 Medications for Weight Loss

Key Market Players: Glucagon-like Peptide-1 (GLP-1) Agonists Market Leaders Novo Nordisk Eli Lilly and Company AstraZeneca Sanofi Pfizer

Volpe S, Lisco G, Racaniello D, Fanelli M, Colaianni V, Vozza A, et al

day 5, 12 nmol/kg

13 Preoperative Risk Assessment Clinicians (e.g., pre-operative assessment clinicians, anesthesiologists) Preprocedural/Pre-imaging Risk Assessment Clinicians (e.g., interventional radiologists, proceduralists, gastroenterologists, anesthesia team) Ask specifically about the patients use of GLP-1 receptor agonists and document the dose and indication when conducting a best possible medication history for patients requiring gastric emptying and sedation

A 2021 review of 13 studies reached a similar conclusion, finding that GLP-1 receptor agonist treatment caused between 11.2 to 13.6 pounds of weight loss over periods ranging from 12 to 68 weeks

As such, we did not consider open-label status as a source of bias, given that measurement of HbA 1c is an objective outcome and thus is not affected by blinding status [15]